Mark Whitlock Email
Statistics Disease Area Head for Hepatology, Fibrosis and Inflammation, Neuro, Renal and GI @ GSK
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Mark Whitlock Location
- Cambridge, GB
Mark Whitlock Work
- Statistics Disease Area Head for Hepatology, Fibrosis and Inflammation, Neuro, Renal and GI @ (September 2025 - Present)
- Statistics Disease Area Head for Hepatology and GI and Renal and for Immunology @ (January 2024 - September 2025)
- Statistics Disease Area Head for Hepatology and GI and Renal @ (July 2023 - January 2024)
- Vice President, Statistics Group Head, Inflammation and Immunology, Early Clinical Development, Pfizer @ (October 2021 - July 2023)
- Director. Head of Sandwich Pharm Sci Statistics Group. @ (March 2010 - July 2011)
- Non-Clinical Statistician. Pharm Sci Statistics Group. @ (February 1999 - March 2010)
- Executive Director - Statistics Group Head, Internal Medicine, Early Clinical Development, Pfizer @ (January 2020 - October 2021)
- Senior Director - Statistics Group Head, Internal Medicine, Early Clinical Development, Pfizer @ (April 2017 - January 2020)
- Senior Director - Head of Statistics, UK Neuroscience and Pain Research Unit, Pfizer @ (January 2015 - April 2017)
- Director - Research Statistician, Pfizer Neusentis @ (July 2011 - January 2015)
Mark Whitlock Education
- University of Kent
PhD (Statistics)
1995-1999 - University of Kent
MSc (Distinction) (Statistics)
1994-1995 - University of Kent
BA (Maths & Economics)
1991-1994
Mark Whitlock Skills
- Statistics
- Multivariate Analysis
- Design of Experiments
- Quality by Design
- Bayesian statistics
- Pharmaceutical Industry
- Experimental Design
- Clinical Research
- Formulation
- Data Analysis
- Biostatistics
- Validation
- Data Mining
- Clinical Development
- Chemometrics
- Clinical Study Design
- Dissolution
- Clinical Trials
- Regulatory Submissions
- SAS
- Lifesciences
- SAS programming
- CRO
- GCP
- Statistical Modeling
- FDA
- Drug Discovery
- Pharmacokinetics
- Drug Development
- Clinical Data Management
- Survival Analysis
- CDISC
- Statistical Programming
- Pharmaceutical Sciences
- Manufacturing
- Research
- 21 CFR Part 11
- Quality Assurance
- Computer System Validation
- Change Control
- Sop
- Project Management
- CAPA
- GMP
- GxP
- Testing
- SDLC
- Documentation
- GAMP
- Application Development
- Risk Assessment
- Audit Support
- Requirements Analysis
- Process Validation
- cGMP
- Requirements Gathering
- Quality Systems
- Systems Analysis
- Analysis
- Troubleshooting
- User Acceptance Testing
- Regression Testing
- System Administration
- Project Planning
- Business Analysis
- Business Requirements
- Business Process
- Requirements Traceability
- Defect Tracking
- Technology Integration
Mark Whitlock Summary
- Mark Whitlock, based in Cambridge, GB, is currently a Statistics Disease Area Head for Hepatology, Fibrosis and Inflammation, Neuro, Renal and GI at GSK. Mark Whitlock brings experience from previous roles at GSK and Pfizer. Mark Whitlock holds a 1995 - 1999 PhD in Statistics @ University of Kent. With a robust skill set that includes Statistics, Multivariate Analysis, Design of Experiments, Quality by Design, Bayesian statistics and more. Mark Whitlock has 1 emails on RocketReach.
Looking for a different Mark Whitlock?
Find contact details for 700 million professionals.
Others Named Mark Whitlock
Mark Whitlock
Managing Director
Dubai, AE
Mark Whitlock
Partner
Washington, IL, US
Mark Whitlock
Sr. Vice President of Sales at APB Fishing
Allen, TX, US
Mark Whitlock
Principal
Trussville, AL, US
Mark Whitlock
Vice President
Birmingham, AL, US
Mark Whitlock
President
Springfield, IL, US
Mark Whitlock
General Dentist and Owner and Operator
Memphis, TN, US
Mark Whitlock
SVP of Revenue Operations and Partner
Chicago, IL, US
Top GSK Employees
Anthony Rowe
VP Onyx Research
United Kingdom
Regis Simard
President Global Supply Chain
England, United Kingdom
Theo Faul
VP General Manager, European Partnership Markets
London, England, GB
Alison Farquhar
VP, Vaccines Commercialization Leader mRNA Next Gen Covid-19 Vaccine
Little Kingshill, GB
Roanne Parry
Chief People Officer
United Kingdom
Maurizio Borgatta
VP and Chief Operations Officer
United Kingdom
Nitin Kapoor
VP, Global Procurement COE
London, GB
Tia Vincent
Vice President, Global Medical Lead, Vaccines
London, England, GB
Neil Wilkinson
CFO, GSK Commercial
Wokingham, GB
Neil Falkingham
Chief Compliance Officer
London, GB
Luke Miels
Chief Executive Officer
London, GB
Julie Brown
Chief Financial Officer and Executive Director
United Kingdom
Tony Wood
Chief Scientific Officer
United Kingdom
Phil Thomson
President, Global Affairs
London, England, GB
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co